At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- In-vitro contractile fatigue protocol (other)
- How long the study runs
- Study runs about 44 months (dates as stated)
- About the drug or intervention
- In-vitro contractile fatigue protocol — other: Using contractility assays for muscle slices or the work-loop assay for isolated heart cells, the tissue preparation will undergo a series of contraction and relaxation under varying levels of preload, afterload, stimulation frequency and under other experimental conditions such as drug-induced inotropism.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years to 85 Years
- Who
- All
- Number of participants
- 100
- Started
- 2021-08-03
- Last checked
- 2024-06
Plain English Summary
What is this study?
- • Testing a new treatment for heart failure
- • Clinical study - 100 participants
- • To gain a comprehensive understanding of the biomechanical behaviour of human heart to explore the concept of myocardial fatigue in response to a temporal range of preload, afterload and drug-induced inotropy using in-vitro contractile assays
Who can take part?
- • Ages 18 Years to 85 Years
- • Diagnosed with heart failure
Where?
- • Coventry - University Hospitals Coventry and Warwickshire
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
To gain a comprehensive understanding of the biomechanical behaviour of human heart to explore the concept of myocardial fatigue in response to a temporal range of preload, afterload and drug-induced inotropy using in-vitro contractile assays.
More detail
A continuum of pathological states from fatigue, injury to damage of the myocardium has been proposed which complements the continuous spectrum of HF and reconciles the seemingly disparate plethora of mechanisms behind the pathophysiology of HF. Unlike skeletal muscle where mechanical stress can be readily removed upon fatigue, an impaired left ventricle continues to receive preload from the right ventricle and cannot rest, maintaining cardiac output only at the expense of increasing filling pressures (as in HF with preserved ejection fraction). If concurrently faced with high afterload from vascular stiffness, ventricular-arterial decoupling occurs, driving mechanical inefficiency and diminishing cardiac output (as in HF with reduced ejection fraction). Chances of recovery is linked to the degree of fatigue, cardiomyocyte loss and replacement with non-contractile fibrosis. Assuming that the myocardium is in a state of chronic fatigue before reaching advanced stages of fibrosis, cases such as aortic stenosis or hypertensive heart disease may potentially be reversible if the pathological load is promptly removed. This study will be re-synthesizing existing knowledge of the biomechanical behaviour of healthy and diseased cardiac myocytes and muscle in a new light of the theoretical constructs of myocardial fatigue, aligned with the existing energy-starvation theory. It will be a proof-of-concept study. Just as Frank-Starling's relationship between preload and cardiac output emerged from pre-clinical studies on muscle behaviour with subsequently major clinical implications, this study represents a necessary stepping stone to adding a new layer of insight into the pathophysiology of heart failure (HF).
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years - 85 Years
- Who can join: All genders
Biomarkers mentioned
What the study is looking for
- ✓All adult patients between 18 to 85-years old undergoing open-heart surgery who can undergo the consent process for...
- ✓Healthy donor hearts that are deemed non-transplantable and consent received from a legal representative
Who cannot take part
- ✗Patients who do not have the mental capacity to undergo the consent process
- ✗For the safety of researchers, patients with evidence of ongoing blood-borne infections such as HIV, or a recent...
See the full criteria
Where Is This Study? (1 UK site)
University Hospitals Coventry and Warwickshire
Coventry CV22DX, United Kingdom
How to Get in Touch
Patrick Tran
Sponsor contactCONTACT
Patrick Tran
Sponsor contactCONTACT
